Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation



Status:Active, not recruiting
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:10/6/2018
Start Date:September 2014
End Date:September 2019

Use our guide to learn which trials are right for you!

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation: A Pilot Study

The purpose of this study is to better understand the risk factors and causes of diabetes in
people who received radiation to the abdomen as children. The investigators hope this
information will allow them to improve how they screen people at risk for diabetes and how
they treat patients in the future.


Inclusion Criteria:

- Diagnosis of childhood cancer between 0-21 years of age

- Prior treatment with abdominal radiation at MSKCC

- Two or more years from completion of therapy

- Records of cancer diagnosis and treatment (including radiation records) available

Exclusion Criteria:

- Known diagnosis of diabetes

- Previous treatment with any radiation impacting the brain (cranial radiation,
craniospinal radiation, total body irradiation)

- Neurocognitive deficits that impair ability to give informed consent or assent

- Patients predicted to have difficult intravenous access, who will likely require
multiple venipuncture attempts
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Phone: 212-639-7376
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials